Design and synthesis of novel (S)-Naproxen hydrazide-hydrazones as potent VEGFR-2 inhibitors and their evaluation in vitro/in vivo breast cancer models-Reference-Cited by-同舟云学术

Design and synthesis of novel (S)-Naproxen hydrazide-hydrazones as potent VEGFR-2 inhibitors and their evaluation in vitro/in vivo breast cancer models

Published:2021-05 Issue: Volume:37 Page:116097
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Han M. İhsan,Atalay Pınar,Tunç Cansu Ümran,Ünal Gökhan,Dayan Serkan^ORCID,Aydın Ömer,Küçükgüzel Ş. Güniz

Funder

Erciyes Universitesi

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference40 articles.

1. Cancer is a preventable disease that requires major lifestyle changes;Anand;Pharm Res,2008

2. A breast cancer prediction model incorporating familial and personal risk factors;Tyrer;Statist Med,2004

3. Triple-negative breast cancer: risk factors to potentialtargets;Schneider;Clin Cancer Res,2008

4. Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer;Tamimi;Breast Cancer Res Treatment,2012

5. Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs);Rainsford;The Am J Med,1999

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, characterization, and MAO inhibitory activities of three new drug-like N-acylhydrazone derivatives;Journal of Molecular Structure;2024-12

2. Novel 1,2,4-triazole-maleamic acid derivatives: synthesis and evaluation as anticancer agents with carbonic anhydrase inhibitory activity;Journal of Molecular Structure;2024-10

3. Exploring etofenamate hydrazide-hydrazone/copper(II) complexes: Synthesis, anticancer activity, carbonic anhydrase IX inhibition and docking studies;Journal of Molecular Structure;2024-09

4. Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐b]pyridazine hybrid derivatives as VEGFR selective inhibitors;Archiv der Pharmazie;2024-07-15

5. Novel 1,3,4‐oxadiazole derivatives of naproxen targeting EGFR: Synthesis, molecular docking studies, and cytotoxic evaluation;Drug Development Research;2024-07-02